Trial intelligence / Profile preview

DMXB-A in Overweight/Obese Adults

NCT02458313Phase 1Completed

Sponsor
University of Colorado Denver
Start
Apr 2016
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in obesity comparing DMXB-A with Placebo (2 arms). Primary endpoints: Neuronal Response to Visual Food Cues at 14 weeks and Resting-state Neuronal Response at 14 weeks. Started Apr 2016; status: completed.

02

Drugs

dmxb-a
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02458313.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02458313.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call